For example, plasma total tau (T-tau) increases in AD [13] but it seems to have limited clinical utility, and phosphorylated form of tau (P-tau) has proven difficult to establish as a reliable measure in blood despite recent promise [14]. The gene discussed is MAPT; the disease is Alzheimer disease.